Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: OPALINE Study focuses on patients with pNET. 2 targeted therapies (TT) offer new options to treat these patients: mTORi (everolimus) and a multi-targeted inhibitor (sunitinib).
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Lombard-Bohas C, Lepage C, Vicaut E, Dominguez S, Coriat R,
Keywords: pNET, targeted therapies,
Introduction: OPALINE Study focuses on patients with pNET. Two targeted therapies (TT) offer new options to treat these patients: mTORi (everolimus) and a multi-targeted inhibitor (sunitinib).
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Lombard-Bohas V
Authors: Lombard-Bohas C, Lepage C, Vicaut E, Dominguez S, Coriat R,
Keywords: pNET, targeted therapy,
Introduction: Patients (pts) with metastatic or locally advanced, non-resectable, grade 1 or 2 Well-differentiated duodeno-pancreatic (WDDP) NETs are treated following European guidelines. Pts with aggressive disease, i.e. progressive and/or symptomatic metastases and/or with significant hepatic invasion (> 30-50%), and/or bone metastases, anti-tumour therapy should receive systemic combination of chemotherapy once disease control is obtained.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Lepage C
Authors: Lepage C, Dahan L, Legoux J, Le Malicot K, Guimbaud R,
Keywords: Duodeno-pancreatic neuroendocrine tumours, clinical trial, maintenance,